Amanda H. Laabs
CIK 2061266 · View on SEC EDGAR ↗
First SEC filing: Dec. 17, 2025 · Latest: June 17, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 15, 2026 | MDLN | F | 1,889 | $36.61 | $69,156 | 23,899 Direct | -7.33% | Disposed | -7.3% (price as of 2026-08-20) |
| March 5, 2026 | MDLN | A | 25,788 | — | — | 25,788 Direct | — | Acquired | (price as of 2026-08-20) |
| Dec. 16, 2025 | MDLN | A | 220,813 | — | — | 220,813 Indirect | — | Acquired | (price as of 2026-08-20) |
| Dec. 16, 2025 | MDLN | A | 132,771 | — | — | 132,771 Indirect | — | Acquired | (price as of 2026-08-20) |
| Dec. 16, 2025 | MDLN | A | 189,352 | — | — | 189,352 Indirect | — | Acquired | (price as of 2026-08-20) |
| Dec. 16, 2025 | MDLN | A | 1,242,391 | — | — | 1,242,391 Indirect | — | Acquired | (price as of 2026-08-20) |
| Dec. 16, 2025 | MDLN | A | 251,070 | — | — | 251,070 Indirect | — | Acquired | (price as of 2026-08-20) |
| Dec. 16, 2025 | MDLN | A | 251,070 | — | — | 251,070 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | MDLN | Incentive Units of Medline Holdings, LP | Class A Common Stock (220,813) | — | — | 220,813 | Acquired |
| Dec. 16, 2025 | MDLN | Incentive Units of Medline Holdings, LP | Class A Common Stock (132,771) | — | — | 132,771 | Acquired |
| Dec. 16, 2025 | MDLN | Incentive Units of Medline Holdings, LP | Class A Common Stock (189,352) | — | — | 189,352 | Acquired |
| Dec. 16, 2025 | MDLN | Incentive Units of Medline Holdings, LP | Class A Common Stock (1,242,391) | — | — | 1,242,391 | Acquired |
| Dec. 16, 2025 | MDLN | Common Units of Medline Holdings, LP | Class A Common Stock (251,070) | — | — | 251,070 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 17, 2025 | MDLN | Class B Common Stock | 251,070 | Direct |
| Dec. 17, 2025 | MDLN | Common Units of Medline Holdings, LP→ Class A Common Stock (251,070) | 251,070 | Indirect |
| Dec. 17, 2025 | MDLN | Incentive Units of Medline Holdings, LP→ Class A Common Stock (1,242,391) | 1,242,391 | Indirect |
| Dec. 17, 2025 | MDLN | Incentive Units of Medline Holdings, LP→ Class A Common Stock (189,352) | 189,352 | Indirect |
| Dec. 17, 2025 | MDLN | Incentive Units of Medline Holdings, LP→ Class A Common Stock (132,771) | 132,771 | Indirect |
| Dec. 17, 2025 | MDLN | Incentive Units of Medline Holdings, LP→ Class A Common Stock (220,813) | 220,813 | Indirect |